| advertisement |
|
|
|
Home | About | Donate/Volunteer | Contact | Jobs |  Early Schizophrenia Screening Test  pen(
url,
"popup_window",
hstr
+ wstr
+"screenX=250,"
+"screenY=50,"
+"resizable=yes,"
+"scrollbars=yes,"
+"status=no,"
+"toolbar=no,"
+"directories=no,"
+"menubar=no" );
popupWindow.focus();
}
ADDING="0" CELLSPACING="0" BORDER="0">
| |
|
|
|
EPA (Omega 3 Fatty Acid) Useful Add-on Therapy in Schizophrenia Schizophrenia Update | ||||||
|
Sept. 9, 2002 — Ethyl-eicosapentaenoic acid (EPA) may be a useful add-on therapy for schizophrenia, according to results of a randomized, placebo-controlled trial published in the September issue of the American Journal of Psychiatry. Patients who were still symptomatic after six months of standard therapy had a significant reduction in both positive and negative symptoms after 12 weeks of treatment. "Extrapyramidal symp>Early Schizophrenia Screening Test |
|
|
An Introduction to Schizophrenia | ||||||||||
|
General Schizophrenia Information
|
advertisement
|
|
